Ocugen, Inc. (OCGN) Earnings Call Analysis
NASDAQ · Healthcare · Biotechnology
Next earnings call: 2026-08-06
(Q2 2026)
— full calendar
Earnings Reports
-
Ocugen (OCGN) Q1 2026: $37.5M Capital Raise Extends Runway as Three BLA Filings Targeted by 2028
May 05, 2026
-
Ocugen (OCGN) Q4 2025: OCU410 Shows 46% Lesion Reduction, Accelerating Gene Therapy Pipeline Milestones
March 04, 2026
-
Ocugen (OCGN) Q3 2025: $20M Financing Extends Runway, OCU400 Nears Phase 3 Completion
November 05, 2025
-
Ocugen (OCGN) Q2 2025: Operating Expenses Drop 8% as Multiple Gene Therapy Trials Hit Milestones
August 05, 2025
-
Ocugen (OCGN) Q1 2025: R&D Spend Jumps 40% as Modifier Gene Therapy Portfolio Advances Toward 3 BLA Filings
July 07, 2025